Litcius/Paper detail

Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero

Ralley Prentice, Emma Flanagan, Emily K. Wright, Peter R. Gibson, Sam Rosella, Ourania Rosella, Jakob Begun, Yoon‐Kyo An, Ian C. Lawrance, Michael A. Kamm, Miles Sparrow, Rimma Goldberg, Lani Prideaux, Sara Vogrin, Katerina Kiburg, Alyson L Ross, Megan Burns, Sally Bell

2024Clinical Gastroenterology and Hepatology23 citationsDOI

Topics & Concepts

MedicineVedolizumabUstekinumabPregnancyObstetricsPediatricsInflammatory bowel diseaseInternal medicineDiseaseAdalimumabBiologyGeneticsPregnancy and Medication ImpactInflammatory Bowel DiseaseReproductive System and Pregnancy
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero | Litcius